2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI